We are live on
!
Find out more
AL
Aspiriant LLC Portfolio holdings
AUM
$4.05B
1-Year Est. Return
19.01%
This Fund
S&P 500
1 Year Est. Return
+19.01%
AUM
$4.05B
AUM Growth
+$540M
(+15%)
Holding
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 | +$145M | |
| 2 | +$3.91M | |
| 3 | +$3.85M | |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$3.23M |
| 5 |
WisdomTree US LargeCap Dividend Fund
DLN
|
+$3.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 | +$4.1M | |
| 2 | +$2.37M | |
| 3 | +$2.16M | |
| 4 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$1.3M |
| 5 |
Cisco
CSCO
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.64% |
| 2 | Financials | 2.01% |
| 3 | Communication Services | 1.23% |
| 4 | Healthcare | 0.74% |
| 5 | Industrials | 0.7% |
Similar funds
VI
RSWM
PI
GCL
PCM
SIC
KRS
PWP
Aspiriant LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Aspiriant LLC held 413 positions worth $4.05B, up 15% from $3.51B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Aspiriant LLC deployed $201M of net new capital in Q2 2026, opening 75 new positions and adding to 186 existing holdings. Its largest new stake was Eagle Capital Select Equity ETF: 58,062 shares worth $1.87M.
By sector, the portfolio is most concentrated in Technology at 3.6% of assets, up from 3.5% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was NVIDIA, an estimated $2.37M trimmed.
- Aspiriant LLC's largest Q2 2026 buy was Eagle Capital Select Equity ETF: 58,062 shares worth $1.87M.
- Aspiriant LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $145M increase.
- Aspiriant LLC's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $2.37M.
- Aspiriant LLC fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q2 2026, selling an estimated $4.1M.
- Aspiriant LLC's ten largest holdings make up 64% of its $4.05B portfolio in Q2 2026.
- Aspiriant LLC opened 75 new positions and closed 13 in Q2 2026.
- Aspiriant LLC's portfolio value rose 15% quarter-over-quarter to $4.05B.
Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.